n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, February 9th, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Viking Energy Group, Inc. (VKIN)

SMS Penny Picks, Greenbackers, SmallCapFinancialWire, Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, FatCat Stocks, Wall Street Beauties, WINNINGOTC, and UndiscoveredEquities reported earlier on Viking Energy Group, Inc. (VKIN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Viking Energy Group, Inc. is an independent exploration and production corporation whose shares trade on the OTC Markets Group’s OTCQB. The Company targets under-valued assets with realistic appreciation potential. Viking Energy owns oil and gas leases in Kansas, Missouri, and the Province of Alberta. The Company has its head office in New York, New York

Viking Energy, by way of its wholly-owned subsidiary, Mid-Con Petroleum, LLC, owns a working interest in 7 producing oil leases with access to the mineral rights (oil and gas) concerning approximately 800 acres of property in Miami and Franklin Counties in Eastern Kansas. The Company’s working interests (WI’s) in the leases range from 68 percent to 100 percent.

In Missouri, Viking Energy owns a 100 percent W1 (about NRI 83 percent) in 31 leases, with access to the mineral rights (oil and gas) regarding roughly 5,500 acres of property in Cass and Bates Counties.

In the Province of Alberta, Viking Energy has a Joint Venture (JV) with Tanager Energy, Inc. The Company’s investment with Tanager Energy includes a 50 percent WI in the Joffre Project, consisting of 4 oil wells and one water injection well. Tanager Energy’s initial project incorporates the Leduc D-3 B Pinnacle Reef in Central Alberta, which is where the Joffre D-3 Oil Project is positioned (the Joffre Project).

Fundamentally, Viking Energy purchases interests in producing, long-life, low-cost oil properties producing positive cash-flow. The Company is not considering speculative exploration programs. It targets properties with current production and untapped reserves for future benefit. Viking centers on acquiring under-valued, producing properties from distressed vendors or those considered as non-core assets by larger sector participants.

Recently, Viking Energy Group announced that it acquired additional working interests in a variety of oil and gas-related leases in Eastern Kansas. On September 11, 2017, Viking, via a wholly-owned subsidiary, Mid-Con Drilling, LLC, acquired a 90 percent WI in four new oil and gas leases in Anderson County in Eastern Kansas, consisting of roughly 980 acres of property.

On October 5, 2017, Viking Energy Group announced that it acquired additional working interests in various oil and gas-related leases in Kansas. This was its third acquisition in less than 30 days. On October 4th, 2017, Viking, via Mid-Con Drilling, acquired, effective September 1, 2017, an 80 percent WI in six new oil and gas leases in Riley, Geary, and Wabaunsee Counties in Kansas.

Viking Energy Group, Inc. (VKIN), closed Friday's trading session at $0.2149, up 27.30%, on 15,034 volume with 11 trades. The average volume for the last 60 days is 26,289 and the stock's 52-week low/high is $0.09/$0.34.

ASAP Expo, Inc. (ASAE)

InvestorsHub, MarketWatch, Market Exclusive, and Barchart reported on ASAP Expo, Inc. (ASAE), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

ASAP Expo, Inc. (dba ASAP International Holdings) is a holding company headquartered in Los Angeles, California. It operates real estate, investment banking, and consulting for Chinese companies. ASAP Expo’s work is to be the bridge between China and the Western world. Established in 2010, ASAP Expo lists on the OTC Markets Group’s OTCQB.

The Company, in the past few years, is one of the most active hotel buyers in the U.S. It has consulted with its clients, with successful acquisitions of more than 31 hotels, with a total value of greater than $1 Billion. ASAP Expo’s Real Estate division assists institutional and high net-worth individuals with acquisition advisory and asset management.

In essence, ASAP Expo is a worldwide investment management company. It specializes in acquisitions advisory and asset management devoted to maximizing value for a diversified equity partners base.

ASAP previously successfully advised on the acquisition for UHON, Inc. of The Shores Resort and Spa in Daytona Beach, Florida that closed on November 1, 2016. UHON established as a real estate development and investment company in August of 2015 in North America.

ASAP announced in January of this year that it successfully acquired The Renaissance Woodbridge Hotel located in 515 US-1, Iselin, New Jersey, which closed on November 15, 2016. The hotel (located between Edison and Woodbridge Township) is surrounded by popular attractions. These include the Menlo Park Museum, Rutgers University, and Newark International Airport.

This past May, ASAP Expo announced the acquisition of the DoubleTree by Hilton Salt Lake City Airport hotel, located in Salt Lake City, Utah. The Plasencia Group represented Laurus Corporation in the sale of the 288-guestroom hotel to ASAP Holdings.

The DoubleTree is situated at the heart of the International Center business and manufacturing district near Salt Lake City International Airport. It is ten minutes from the city's downtown area.

Earlier in November, ASAP announced the acquisition of the Hilton Houston Galleria Area hotel, in Houston, Texas. The 293-guestroom hotel was purchased by a new joint venture between Golden Emerald LLC and ASAP. The Hotel is located less than 2 miles from the prestigious Galleria Shopping & Business District. It is j10 miles from downtown Houston. ASAP will renovate the Hotel from a Hilton to a Doubletree.

ASAP Expo, Inc. (ASAE), closed Friday's trading session at $0.026, up 4.00%, on 2,426 volume with 2 trades. The average volume for the last 60 days is 11,550 and the stock's 52-week low/high is $0.022/$0.14.

Voip-Pal.com, Inc. (VPLM)

Clutch Investments, equities Canada, TryBestPennyStocks.biz, UndiscoveredEquities, SmallCapVoice, SmallCapAllStars, FeedBlitz, TheSUBWAY, Stock Twiter, Google Alerts, Pumps and Dumps, Equities, VC Stock Marketing, and Buzz Stocks reported earlier on Voip-Pal.com, Inc. (VPLM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Voip-Pal.com, Inc. owns a portfolio of patents relating to Voice-over-Internet Protocol (VoIP) technology. The Company is currently looking to monetize its fundamental patents via a sale or licensure of its technology. In December 1997, Voip-Pal.com incorporated in the State of Nevada. In 2013, the Company acquired Digifonica International (DIL) Limited to fund, co-develop, and complete Digifonica's patent collection. Voip-Pal.com is headquartered in Bellevue, Washington.

The Company’s Intellectual Property (IP) value comes from numerous issued US Patent and Trademark Office (USPTO) patents. This includes five parent patents, one of which is foundational and the others which build upon the former. The five core patents are: Routing, Billing & Rating (RBR); Lawful Intercept; Enhanced E-911; Mobile Gateway; and Uninterrupted Transmission.

Voip-Pal.com believes that its Lawful Intercept patents could prove to be an important tool for law enforcement in its efforts to combat crime and stop terror attacks. The technology provides the means for judicially authorized covert intercept of any type of communications sent through VoIP. This includes voice calls, media, and messaging.

The Company’s patented technology provides Universal numbering ubiquity; network value as defined by Metcalfe; the imperative of interconnect, termination, and recompense for delivery of calls by other networks; and regulatory compliance in regulated markets. Furthermore, its patented technology provides interconnection of VoIP networks to mobile and fixed networks; and maintenance of uninterrupted VoIP calls across fixed, mobile, and WiFi networks.

This past December, Voip-Pal.com announced it was granted Notice of Allowance (Intention to Grant) of its main parent patent, Routing, Billing & Rating (RBR) patent by the European Patent Office, European Patent Application No. 07816106.4 (2084868).

The Company also announced the issuance by the USPTO of two new patents. One is US Patent No. 9,813,330, issued on November 7, 2017, Producing Routing Messages for Voice Over IP Communications. The other is US Patent No. 9,826,002, issued on November 21, 2017, Producing Routing Messages for Voice Over IP Communications. Both of these are continuations to the RBR patent.

Voip-Pal.com also received a Notice of Allowance from the USPTO on December 4, 2017, for Patent Application No. 14/325,181, Allocating Charges for Communications Services. This is also a continuation of the RBR patent.

Voip-Pal.com, Inc. (VPLM), closed Friday's trading session at $0.17, up 21.43%, on 802,546 volume with 77 trades. The average volume for the last 60 days is 1,997,080 and the stock's 52-week low/high is $0.0125/$0.45.

TimefireVR, Inc. (TFVR)

Barchart, Stockhouse, Marketwired, InvestorsHub, MarketWatch, and Street Register reported on TimefireVR, Inc. (TFVR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

TimefireVR, Inc. is a software company with a virtual reality platform for immersive, interactive, as well as social experiential learning. The Company formed in early 2014 to develop a virtual reality application platform, Hypatia, built on pillars of social interaction, commerce, cultural immersion, and entertainment. Hypatia is a curated virtual reality destination metaverse of massive scale.

On September 14, 2016, EnergyTek Corp. announced that it merged with Timefire LLC. The Company subsequently changed its name to TimefireVR, Inc. A technology enterprise, TimefireVR is headquartered in Scottsdale, Arizona.

Hypatia is influenced from some of the most visited cities in the world. TimefireVR's VR platform application provides an environment for cooperative participation and experiential learning in a safe environment.

With Hypatia, one can socialize, talking via text or audio. One can also shop; watch videos, concerts, and plays. With Hypatia, a user can create and customize the world about them. Additionally, a user can travel to real cities and fantasy destinations.

In June of 2017, TimefireVR formally launched its exclusive Virtual Reality title Hypatia, its multi-player multi-hour social environment.

However, last month, TimefireVR announced shifting its main corporate emphasis towards the strategic investments in crypto currency and potential acquisitions of blockchain technology businesses. As part of the shift in strategic direction, it sold its virtual reality assets. In addition, it appointed Mr. Jonathan Read to serve as Chief Executive Officer (CEO), Secretary, and Treasurer of TimefireVR.

Mr. Read has been a Director of TimefireVR since August 18, 2017. Since July 14, 2017, he has served as a member of the Board of Directors of BTCS, Inc. (BTCS), a blockchain technology focused company.

Mr. Jonathan Read, TimefireVR’s CEO, said, “Blockchain technology and its application of crypto currencies is an amazing enabling technology paradigm that will have a profound and disruptive impact on a host of industries. I am incredibly proud of our accomplishments in virtual reality; however, the Board of Directors made a strategic decision, in the best interest of our shareholders, to leverage my experience in blockchain technology where I serve as a member of the Board of Directors of BTCS Inc. (OTC Pink:BTCS), our strategic business vision and our ability to access the capital markets immediately.”

TimefireVR announced the sale of its virtual reality assets, mainly the social media/education platform and virtual world “Hypatia” to a group of investors. This includes its original founders, Mr. John Wise and Mr. Jeffrey Rassas. The expectation is that Hypatia will be a VR destination content leader. Consistent with this sale, TimefireVR expects to change its name following Board and shareholder approval.

At first, TimefireVR will concentrate on Ethereum, which is a foremost blockchain platform for Decentralized Applications (DApps). These are applications that run on a peer-to-peer network of computers instead of on one single computer or server.

TimefireVR, Inc. (TFVR), closed Friday's trading session at $0.034, down 10.53%, on 1,202,546 volume with 92 trades. The average volume for the last 60 days is 2,662,026 and the stock's 52-week low/high is $0.0111/$0.55.

Innovation Pharmaceuticals, Inc. (IPIX)

Investors Hangout, Stockdigest Report, Stockhouse, and InvestorsHub reported on Innovation Pharmaceuticals, Inc. (IPIX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Innovation Pharmaceuticals, Inc. is a clinical stage biopharmaceutical enterprise. The Company is developing unique therapies in numerous diseases. Its belief is that it has a premier portfolio of first-in-class lead drug candidates. It is currently advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals is based in Beverly, Massachusetts.

The Company has established research collaborations with world-renowned research institutions in the U.S. and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

Innovation’s anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company has started a Phase 2 study in Ovarian Cancer.

Innovation Pharmaceuticals’ Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and the Company more recently launched a Phase 2b study. Prurisol is a small molecule. It acts through immune modulation and PRINS reduction.

Brilacidin, which is a defensin mimetic compound, has shown in an animal model to decrease the occurrence of severe ulcerative Oral Mucositis (OM) by greater than 94 percent versus placebo. Innovation is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Interim results have shown a marked reduction in the incidence of severe OM (WHO Grade ≥ 3).

Brilacidin has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (superbugs).

In addition, in a continuing Phase 2 open label Proof-of-Concept (PoC) trial, favorable interim results were observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two kinds of Inflammatory Bowel Disease (IBD).

Yesterday, Innovation Pharmaceuticals announced the closure of its Phase 2a clinical trial of Kevetrin for the treatment of late-stage Ovarian Cancer (OC). The Company started the trial for the purpose of demonstrating modulation of the key tumor-suppressor protein p53 that was achieved in analysis of the first patients at the lowest dose of Kevetrin.

Kevetrin (throughout pre-clinical testing and two successful clinical trials) has demonstrated promising signs of efficacy as an anti-cancer agent and a favorable pharmacokinetic profile, which includes a very short half-life and good bioavailability.

Innovation Pharmaceuticals, Inc. (IPIX), closed Friday's trading session at $0.675, down 2.17%, on 277,424 volume with 108 trades. The average volume for the last 60 days is 267,556 and the stock's 52-week low/high is $0.63/$1.17.

MassRoots, Inc. (MSRT)

CFN Media Group, Wealth Daily, Cannabis Financial Network News, Equities, The Street, Promotion Stock Secrets, Stock Commander, PennyStockLocks, PennyStockScholar, Profitable Trader Authority, SmallCapVoice, Penny Stock 101, Money Morning, Stock News Now, OTCtipReporter, StockRockandRoll, SeeThruEquity Research, Damn Good Penny Picks, Penny Picks, and OTCJournal reported earlier on MassRoots, Inc. (MSRT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

MassRoots, Inc. is a foremost technology platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. These include the ArcView Group and the National Cannabis Industry Association. OTCQB-listed, MassRoots is based in Denver, Colorado.

Businesses can use MassRoots to advertise their goods and services to cannabis consumers. MassRoots starts adding in features. These include order ahead, delivery, and the in-app purchase of ancillary products as regulations allow.
MassRoots has some estimated 300-plus dispensaries actively posting on its network.

The Company’s product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. Most of the Company’s advertising revenue has come from dispensaries and cannabis-brands in California and Colorado.

MassRoots completed its acquisition of DDDigtal, d.b.a. "Whaxy" in January of 2017. This is an online order-ahead and menu management platform. MassRoots has made a strategic investment in High Times Holding Corporation, "High Times", which is the leading voice of the Cannabis Industry.

MassRoots has acquired Odava, Inc. MassRoots now offers dispensaries a complete set of software to manage their regulatory compliance, streamline their supply chain, and develop successful consumer loyalty programs. Odava is a leading compliance and point-of-sale (POS) system for the cannabis industry.

MassRoots also acquired CannaRegs, Inc. It entered into a definitive agreement to acquire CannaRegs in a stock deal valued at about $12 million. CannaRegs is a top technology platform. It tracks changes in cannabis regulations and taxation at the municipal, state, and federal levels.

MassRoots and New Frontier Data have partnered to elevate digital marketing practices and better understand social consumer behavior at a crucial time in the cannabis industry. New Frontier Data is the foremost provider of data, analytics and business intelligence in the cannabis industry. New Frontier Data's data engine will allow MassRoots to aggregate, analyze, and monetize the large volume of consumer engagement data undergoing collection by the MassRoots mobile application and website.

Recently, MassRoots announced the early-stage testing of a new concierge service for cannabis enthusiasts. This service marks a new partnership with Diem Cannabis, an Oregon-based dispensary and delivery service. Early tests will be available throughout Portland and nearby Salem. These will provide delivery customers with a virtual budtender to help them select the proper order for their particular needs.

MassRoots' new concierge service will enable consumers to speak by phone or text chat with a virtual budtender, ask questions, get recommendations, and verify all information is correct before MassRoots sends the order to Diem. Then, Diem Cannabis will fulfill and deliver the final order to the consumer, accepting payment on delivery.

MassRoots has recently formed MassRoots Blockchain Technologies, Inc. This is a wholly-owned subsidiary of MassRoots dedicated to developing blockchain-based solutions for the cannabis industry.

MassRoots Chief Executive Officer, Isaac Dietrich, said, "We believe blockchain has the potential to enable the cannabis industry to operate more efficiently and with a greater degree of accountability and transparency. MassRoots looks forward to being a pioneer in exploring blockchain-based solutions for the multi-billion dollar cannabis industry."

MassRoots, Inc. (MSRT), closed Friday's trading session at $0.3975, up 3.38%, on 1,253,242 volume with 323 trades. The average volume for the last 60 days is 2,615,645 and the stock's 52-week low/high is $0.1156/$1.17.

Astea International, Inc. (ATEA)

Stocktwits, Stockhouse, Zacks, OTC Markets, MarketWatch, InvestorsHub, Business Insider, and The Street reported on Astea International, Inc. (ATEA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Astea International, Inc. is an international leader in field service and mobile workforce management. Its solutions unify processes, people, parts, and information to center the whole organization on the creation of sustainable value in highly competitive, global markets. Astea provides integrated solutions to help in maximizing efficiencies, improve revenues, and enhance customer satisfaction.

Astea International has its corporate office in Horsham, Pennsylvania. The Company was recognized by Frost & Sullivan with the 2017 Customer Value Leadership Award for its industry-leading mobile workforce management solution.

Astea International is a worldwide provider of end-to-end service management software solutions. These solutions offer all the foundations of service lifecycle management. These include customer management, depot repair, service management, asset management, warranty management, forward and reverse logistics management, and mobile workforce management and optimization.

The Company has expertise in service management, distribution, logistics, as well as system applications. These can help an organization streamline business processes, incorporate services best practices, lessen costs, and attain the highest returns from their technology investment. The principal elements of Astea’s professional services are impact assessment, consulting services, and training & support.

Astea International provides on-premise and cloud delivery models. This allows every company to choose the right one that aligns with their strategy and Information Technology (IT) ecosystem.

The Company’s solutions enable companies to streamline and automate business processes; condense the contract-to-cash cycle; collapse non-value added workflows, and enhance resource utilization and lessen downtime. The Company has licensed applications to enterprises around the world in a broad spectrum of sectors.

In addition, Astea’s solutions allow companies to Identify incremental sales opportunities and improve revenue recovery and coordinate the efforts of sales, marketing, and service organizations. Its solutions also permit companies to improve compliance with Service Level Agreements (SLAs), contracts, and warranties, as well as harmonize every customer touch point for increased customer satisfaction.

Astea International, by way of its Japanese subsidiary, has partnered with Kobelco Systems Corporation. This is to enable comprehensive Internet of Things (IoT) and Artificial Intelligence (AI) capabilities on its field service management platform, Astea Alliance™.

Kobelco Systems' IoT infrastructure platform and AI analytical service are now totally integrated into the Astea Alliance platform to optimize the maintenance activities of original equipment manufacturers (OEMs), improving overall productivity for assembly lines, plants, and supply chains.

This past November, Astea International announced it was positioned by Gartner, Inc. in the "Niche Players" quadrant of the 2017 "Magic Quadrant for Field Service Management*" report based on its "product breadth, product depth and strong customer retention." This report cites the Company as having "one of the highest customer retention percentages of any vendor," "one of the market's few end-to-end field service products," and a highly modernized and configurable mobile application.

Moreover, in November, Astea International announced that it was named one of the 10 Fastest Growing SaaS Solution Providers for 2017 by The Silicon Review Magazine. The publication chose Astea International based on its technology fluency, strong customer connections, tactical strategies, problem solving techniques, and also its belief in true innovation.

Astea International was noted for empowering service organizations to embrace new business models and grow revenue. This is while maintaining a competitive position in today's highly-competitive service industries.

Astea International, Inc. (ATEA), closed Friday's trading session at $3.35, up 8.06%, on 74,928 volume with 167 trades. The average volume for the last 60 days is 126,868 and the stock's 52-week low/high is $0.20/$3.8799.

Choom Holdings, Inc. (CHOOF)

Barchart, MarketWatch, InvestorsHub, Stockhouse, 4-Traders and Dividend Investor reported on Choom Holdings, Inc. (CHOOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Choom Holdings, Inc. is engaging in the fast growing legal cannabis industry in Canada. This is with its own brand of high-grade handcrafted herb. Choom™ was established to cultivate Cannabis for the Canadian adult consumer. The Company previously went by the name Standard Graphite Corporation. It changed its name to Choom Holdings, Inc. in November of 2017.

Choom Holdings has its corporate office in Vancouver, British Columbia (B.C.). The Company’s shares trade on the OTC Markets Group’s OTCQB.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November of 2013 in Vernon, B.C. The Company has security clearance and is now in the detailed review stage.

The Company’s second ACMP has confirmation of readiness. Its focus is on attaining a license to produce and sell high-grade handcrafted cannabis in Canada.

Choom™ has a planned Phase 1 cannabis production facility, which will have the capability to produce roughly 660 kg of dried cannabis yearly. The planned Phase 2 expansion plans, within the existing facility, would increase the Company’s cannabis production capacity to approximately 1,500 kg per annum.

The Company’s second Choom™ ACMPR Vancouver Island production capacity is about 450 kg. The addition of Phase 2 approximately combined equals 900 kg.

Furthermore, Choom is going to develop a chain of branded retail cannabis dispensaries. These will be in jurisdictions in Canada where recreational cannabis is legalized for retail.

Last month, Choom™ announced that it signed a Letter of Intent (LOI) to acquire its second, advanced-stage cannabis production license applicant (Target) under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The target is on Vancouver Island, B.C. The target is at the "Confirmation of Readiness Stage" within the Health Canada "ACMPR" application process.

Choom Holdings will acquire all of the shares of Target. It will become a wholly-owned subsidiary of Choom Holdings.

This week, Choom Holdings announced its retail program. The Company is now opening the Choom™ family up to potential individual store investors.

Mr. Chris Bogart, Choom Holdings’ President and Chief Executive Officer, said, "Choom™ is using design and retail strategies that have worked successfully at some of the most profitable storefronts in the country. We are telling our Choom™ story with our stores and will elevate the concept of a high-quality product though our new retail environments, and we're inviting others to join us."

Choom Holdings, Inc. (CHOOF), closed Friday's trading session at $0.59, down 0.19%, on 98,982 volume with 76 trades. The average volume for the last 60 days is 39,676 and the stock's 52-week low/high is $0.11/$0.8612.

United Cannabis Corp. (CNAB)

Stockgoodies, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Market Intelligence Center Alert, Marketbeat, StreetAuthority Daily, Actual Gains, Broad Street, TopPennyStockMovers, StocksImpossible, Cannabis Financial Network News, PricelessPennyStocks, PennyStockRumors.net, Money Map Press, MyBestStockAlerts, and Wall Street Wolves reported earlier on United Cannabis Corp. (CNAB), and we also report on the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s commitment is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company established to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, and services. A biotechnology enterprise, the Company is the creator of Prana Bio Nutrient Medicinals. United Cannabis has its head office in Denver, Colorado.

The Company provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. It owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products. It has established affiliate relationships with Harborside Health Center of California, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, and Cannabinoid Research & Development (CRD).

The United States Patent and Trademark Office (USPTO) issued US Patent #9730911, granting exclusive rights to the Company’s proprietary formulations based on compounds extracted from cannabis plant materials. More precisely, it is the composition of matter pertaining to the use of phytocannabinoids, cannabinoids, and specific terpene profiles in liquid form.

United Cannabis’ A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a total solution designed to allow physicians and patients to implement and monitor effective therapy protocols. Prana Bio Nutrient Medicinals is a complete, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and manifold non-abrasive delivery methods.

The A.C.T. Now program provides nutritional recommendations to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many types of cancer.

United Cannabis has acquired a majority share of Prana Therapeutics, Inc. (PTI). Prana is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopedic markets. Prana centers on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis, and treatment of brain cancer.

Recently, United Cannabis announced that it secured an industrial building in Colorado. The Company will build a state-of-the-art industrial hemp processing plant to provide contract manufacturing to farmers working under the 2014 Federal Farm Bill and Colorado's Department of Agriculture's Industrial Hemp Program. The multi-function Facility will include extraction, purification, testing and processing equipment, and also packaging, fulfillment, and secure storage capabilities.

United Cannabis has entered into a non-exclusive licensing agreement with Harborside Health Association LLC (HHA), encompassing United Cannabis’ patented methods of extracting, preparing, and using cannabis. With this Agreement, United Cannabis assigned HHA the rights to the methodologies needed to manufacture and distribute its own proprietary line using United Cannabis' patented technology, in exchange for which, HHA will pay the Company an agreed upon licensing fee.

This month, United Cannabis announced that it established a Limited Partnership between the Company, LASCO Manufacturing Limited (LASCO), and United Cannabis' Jamaican Partner, Cannabinoid Research & Development Co. Ltd. LASCO is one of the foremost dry blend beverage companies in Jamaica.

Furthermore, United Cannabis announced that it signed an exclusive License Agreement with LASCO to produce the Company's CBD water and other Bio Nutrient Medicinals in the form of Capsules, Sublinguals, Roll-ons, and Balms for the English-speaking Caribbean and Central America, excluding Mexico.

United Cannabis Corp. (CNAB), closed Friday's trading session at $1.16, up 4.92%, on 244,692 volume with 274 trades. The average volume for the last 60 days is 618,340 and the stock's 52-week low/high is $0.535/$2.50.

graphic

The QualityStocks
Company Corner

graphic
graphic

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.121, off by 6.96%, on 43,500 volume with 5 trades. The stock’s average daily volume over the past 60 days is 49,069, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

“NEW TO THE STREET” TV Announces Exciting New Companies to Commence Filming for Nationwide Fox Business TV Broadcast, Including Reign Sapphire Corp. (OTCQB: RGNP)

Reign Sapphire Corp. (RGNP) is “One to Watch”

NetworkNewsBreaks – Reign Sapphire Corp. (RGNP) Details Key Features of Sapphire-Backed Cryptocurrency

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.098, off by 2.00%, on 569,318 volume with 69 trades. The stock’s average daily volume over the past 60 days is 970,787, and its 52-week low/high is $0.0045/$0.52.

Epazz, Inc. (EPAZ) spokesman Matt Chipman announced the company's Zenapay app has surpassed 20,000 downloads recently and the company was featured on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs, providing insights into their operations and outlooks for their futures.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

MoneyTV with Donald Baillargeon, 2/9

NetworkNewsAudio Announces Audio Press Release (APR) on Blockchain Powers Cutting-Edge Service and Support

Keeping Track of Cryptocurrency Trends and Live Trading with Epazz, Inc. (EPAZ) Mobile Apps

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.69, up 2.99%, on 87,990 volume with 94 trades. The stock’s average daily volume over the past 60 days is 251,735 and its 52-week low/high is $0.40/$1.90.

With the rapid growth of the legal American cannabis market, other cannabidiol (CBD)-based products are often overlooked. In particular, hemp has the opportunity to reach medical and nutritional customers that cannabis can’t, and ChineseInvestors.com (CIIX) is tapping into that market. With the potential to provide similar benefits without the same restrictions, hemp products can be sold in markets such as China, where cannabis remains illegal.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

NetworkNewsWire Announces Publication on HEMP Opportunities for Investors Looking in Wider Cannabidiol Space

Hemp Provides Investors Access to Larger Cannabidiol Market

ChineseInvestors.com, Inc. Announces its Wholly-Owned Foreign Enterprise, CBD Biotechnology Co. Ltd.'s New Luxury Skincare Products Have Been Approved by the CFDA and Will Launch in China in February 2018

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.0228, off by 3.72%, on 97,026 volume with 10 trades. The stock’s average daily volume over the past 60 days is 230,052 and its 52-week low/high is $0.02/$0.33.

Skinvisible, Inc. (OTCQB: SKVI) is working toward developing a transdermal treatment for post-traumatic stress disorder through its patented Invisicare® technology that could address the devastating number of veteran suicides that occur throughout the country. The company’s proposed merger with Quoin Pharmaceuticals would direct Skinvisible’s drug delivery capacity to boost the bioavailability of Quoin’s promising pharmaceuticals.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

NetworkNewsBreaks – Skinvisible, Inc.’s (SKVI) DermSafe Offers Long-term Protection Against H3N2 Flu Virus

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.44945, off by 4.37%, on 8,963,041 volume with 2,088 trades. The stock’s average daily volume over the past 60 days is 12,708,246, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding Inc. (OTC: POTN) has reported favorable monthly sales data and a strong quarterly filing in its drive to produce high-grade CBD for use in oils, tinctures, edibles and vape liquids. This performance is, in turn, generating forecasts for a heightened share price. The holding company for a number of subsidiaries in the hemp-extract medical cannabis industry, PotNetwork has been named ‘One of Five Notable CBD Revolution Industry Leaders’ by media outlet The Huffington Post.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

CannabisNewsBreaks – PotNetwork Holding Inc. (POTN) Sales Drive Optimistic Share Price Target

Recent Report on PotNetwork Holding Inc. (POTN) Share Price Target Highlights Encouraging Data

Diamond CBD Inc. Exhibits in Las Vegas at the Tobacco Plus Expo on January 30 - February 1

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0669, off by 4.43%, on 6,034,876 volume with 376 trades. The stock’s average daily volume over the past 60 days is 14,303,264, and its 52-week low/high is $0.0132/$0.415.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTC:SING), a client of NNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. To view the full publication, titled “Consumers and Merchants Migrate into Cryptocurrencies in Next Market Evolution,” visit: LINK. Also today, the company was featured on MoneyTV with Donald Baillargeon. The television program can be viewed online immediately at www.moneytv.net.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication on Cryptos Taking Front and Center Amid Market Evolution

SinglePoint Featured on MoneyTV with Donald Baillargeon, 2/9

Consumers and Merchants Migrate into Cryptocurrencies in Next Market Evolution

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.02935, off by 5.32%, on 11,651,329 volume with 281 trades. The stock’s average daily volume over the past 60 days is 15,842,803, and its 52-week low/high is $0.0141/$0.16.

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (OTC:GOHE), a client of CNW and a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. To view the full publication, titled “Opportunity amid Cannabis Banking Hurdles,” visit: LINK

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

CannabisNewsWire Announces Publication on Investment Opportunities as Companies Scale Cannabis Banking Roadblocks

Banking the Unbankable: MoneyTrac Technology, Inc. Aims to Bring Crypto to Cannabis

Opportunity Amid Cannabis Banking Hurdles

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.0108, off by 6.36%, on 39,620 volume with 64 trades. The stock’s average daily volume over the past 60 days is 102,576, and its 52-week low/high is $0.015/$1.8892.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Blockchain's Developing Role in American Infrastructure," featuring Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF). To hear the NetworkNewsAudio version, visit: LINK. To read the original editorial, visit LINK.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Innovators Gearing Up to Execute Blockchain-Powered Solutions

NetworkNewsWire Announces Publication on Blockchain Paving the Way in Multiple Industries

Blockchain Technology Projected to Play a Disruptive Role in Oil and Gas Sector

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.34, off by 15.00%, on 22,152 volume with 13 trades. The stock’s average daily volume over the past 60 days is 7,827, and its 52-week low/high is $0.01/$0.80.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Investment Opportunities in Advanced Bioengineered Drug Delivery," featuring PreveCeutical Medical Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H). To hear the NetworkNewsAudio version, visit: LINK. To read the original editorial, visit: LINK.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Drug Delivery Advancements Bring Attractive Investment Opportunities

NetworkNewsWire Announces Publication on Innovators in New Drug Delivery Systems

Investment Opportunities in Advanced Bioengineered Drug Delivery

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(DBRT) +28.40%

2.

QualityStocks
(VKIN) +27.30%

3.

MarketClub Analysis
(AOI) +22.69%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251